CareDx, Inc. (CDNA) vs NeoGenomics, Inc. (NEO)
- CareDx, Inc. CDNA 63.81 −4.30%
- NeoGenomics, Inc. NEO 16.65 −3.48%
CareDx, Inc. and NeoGenomics, Inc. are both Diagnostics & Research companies. CareDx, Inc. is the larger, with a market value of $3.5B against $2.2B — 1.6× the size. NeoGenomics, Inc. has negative trailing earnings, so its P/E is not meaningful; CareDx, Inc. trades at 29.7×. CareDx, Inc. grew revenue faster over the last twelve months: 34.4% against 11.2%. CareDx, Inc. has the higher net margin (24.2% vs −6.77%) and the higher return on invested capital (130.1% vs −4.20%). Across the 18 metrics below, CareDx, Inc. leads on 13 and NeoGenomics, Inc. on 5.
Valuation
Profitability
| Metric | CDNA | NEO | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 70.58% | 43.92% | 50.89% |
| Operating margin | 23.61% | (8.93%) | (8.57%) |
| Net margin | 24.23% | (6.77%) | (6.37%) |
| Free cash flow margin | 18.49% | (0.69%) | 0.00% |
| Return on equity | 29.49% | (6.33%) | (2.92%) |
| Return on assets | 22.72% | (3.78%) | (6.71%) |
| Return on invested capital | 130.06% | (4.20%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack